Online Mendelian Inheritance in Man (OMIM) (http://www3.ncbi.nlm.nih.gov/omim/) is a publicly available, genetic knowledgebase that is comprehensive and authoritative (1) . It is based on the textbook version of Mendelian Inheritance in Man (MIM), initiated by Victor A. McKusick, MD at The Johns Hopkins University School of Medicine in the early 1960s (2) . The OMIM database was made internationally available online in 1987 by the National Library of Medicine (NLM). It is currently maintained by geneticists and molecular biologists and provides free text overviews of genetic disorders and gene loci. OMIM serves as a single gateway to a wealth of genetic databases through its relevant links, allowing the user to obtain detailed information not only about the clinical phenotypes and genotypes, but also on gene sequence, structure and function, map location, animal models, references, etc. Distribution of the OMIM, software development, and support are provided by the National Center for Biotechnology Information at the NLM.
OMIM entries are created for each unique genetic disorder or gene for which sufficient information exists. Under the direct editorship and authorship of Dr. McKusick, a total of 1487 entries appeared in the first print edition of 1968. The 12th edition of MIM, with approximately 9000 The data presented in this table reflect the information in OMIM at the time of preparation of the manuscript and may not reflect the most current knowledge in the field. * OMIM numbers starting with 1 denote autosomal dominant inheritance (AD); 2 denotes autosomal recessive inheritance; 3 denotes X-linked inheritance; 6 does not indicate type of inheritance so that inheritance is also noted. The numbers usually indicate a disorder, not a gene.
** Mouse models with mutations that differ in mechanism of action from the naturally occurring human mutations are also noted. Genes in brackets indicate alternative names. entries, was published in the summer of 1998, and on December 10, 1999, the total number of entries exceeded 11005. When these disorders are stratified according to inheritance, there are 10292 autosomal, 616 X-linked, 37 Y-linked, and 60 mitochondrial entries. Each OMIM entry is given a unique six-digit number whose first digit can indicate the mode of inheritance of a condition (see Tables 1 and 2 ). In general, congenital abnormalities of non-Mendelian inheritance, chromosomal abnormalities, and single case reports are not included. A detailed description of OMIM, its organization, and search engine is available on the web site (http://www3.ncbi.nlm.nih.gov/omim/symbol. html).
Complexity of developmental disorders
OMIM can be used as an historic record and a current source of information to understand human malformations and their etiologies. Elucidation of the pathogenesis of these conditions has evolved over time with the development of diagnostic tools, such as cytogenetics, biochemical analyses, molecular diagnostics, and most recently, bioinformatics. For example, until the late 1950s, Down syndrome (Trisomy 21, OMIM 190685) and homocystinuria (OMIM 236200) were both regarded as dysmorphic syndromes. In the early 1960s, with the development of cytogenetics and with the introduction of methods for plasma amino acid analysis, the etiologies of these two and many other 'dysmorphic syndromes' were elucidated. Also, these tools have provided evidence that the separation between 'metabolic disorders' (inborn errors of metabolism) and 'malformation syndromes' (inborn errors of development) is an artificial one (3). A good example of an overlap between these two categories is the Smith-LemliOpitz syndrome (OMIM 270400), initially regarded as a dysmorphic syndrome, but more recently also acknowledged to be an inborn error of the cholesterol metabolism as well.
The generic term 'dysmorphic syndrome' indicates abnormal morphologic features. These may be a result of an intrinsically abnormal developmental process in utero (structural defects or malformations) or due to gradual change over time of an initially properly formed body part or system, as in the case of storage diseases. Patients with either Smith-Lemli -Opitz syndrome or Hurler syndrome (OMIM 252800) will present with multiple dysmorphic features, but the timing of the offending events and of the development of the phenotypic features can vary significantly. Although both are caused by a single enzyme deficiency, one enzyme is required for proper organogenesis while the other causes postnatal accumulation of mucopolysaccharides, respectively. Therefore, unlike Smith -Lemli -Opitz syndrome, Hurler syndrome usually is not diagnosed at birth, and other milder mucopolysaccharidoses, such as Sanfilippo syndromes (OMIM 252920) are not recognized until late childhood or even adulthood. Therefore, malformations that present at birth can be more easily diagnosed and classified as disorders of development in which the abnormal morphogenesis occurred during embryogenesis. If compatible with life, an error in embryonic development may lead to a series of abnormal events with the final result of a single abnormality or multiple structural defects at birth.
Keeping in mind the complexity of developmental disorders, this review will be limited to the discussion of clinical phenotypes that present at birth and are due to known gene mutations, ascertained through the use of bioinformatics and the OMIM knowledgebase.
Strategy for analysis of developmental disorders in OMIM
As a starting point in analyzing OMIM for information on 'inborn errors of development', one may access from the home page via the file transfer program (FTP) the OMIM Gene Map and the OMIM Gene Map Key for all entries that have associated chromosome map locations; one may then download the information on these genetic disorders and genes as a text file, or preferably into data-managing computer programs, such as Microsoft Excel or Corel Paradox. On December 10, 1999, there were 5850 entries in the OMIM Gene Map. Each has a number of fields including chromosomal location, gene symbol(s), MIM number, name of the disorder(s), corresponding mouse correlate, and reference. Field 14 -'name of the disorder' -contains a bracketed number: '(1)' for mapped wild-type gene without identified phenotype causing mutations; '(2)' for phenotype mapped to the given chromosomal location; and '(3)' phenotype caused by mutation in a given gene.
For the purposes of identifying developmental disorders, we selected entries that represent an abnormal phenotype (genetic disorder) due to a mutation in a known gene (i.e., entries containing '(3)' in field 14). A set of at least 1231 entries satisfied this criterion when we searched OMIM on November 15, 1999. We then attempted to identify a subset of entries with phenotypes that are evident at or around birth using the OMIM search engine. However, despite multiple searches using different keywords such as 'birth', 'newborn', 'neonatal', 'infantile', 'onset', etc., we were not able to identify all the 'perinatal' phenotypes within our preselected set. The search engine, in its present form, is limited because it does not allow a 'proximity search', where an entry can be searched for a phrase or neighboring words. For example, searching with 'neonatal onset' identified 165 entries, some containing both words as a phrase, and some only the word 'neonatal' or only the word 'onset' within the same entry, regardless of their context and relative order. One of the listed entries for this search was Alzheimer disease (OMIM 104300) even though it is known not to present in the perinatal period. This entry contains the phrases 'age of onset', 'late-onset', and 'neonatal brain', but not 'neonatal onset' or other relevant phrases. Also, Boolean queries, such as '' =or, '−' =but not, and '&'=and, did not capture all relevant entries. Therefore, searches conducted in OMIM are limited by the 'free text' composition of the entries and the lack of fields for phenotypic features.
Therefore, to be accurate and complete, we reviewed all of the 1231 entries individually and selected a subset of 207 entries with phenotypes that are evident at or around the time of birth. Of these, at least 162 entries or disorders have single or multiple congenital anomalies affecting one or more organ system, while the other 45 entries describe phenotypes that are 'functional' (e.g., hypotonia due to congenital myopathy, OMIM 158810, or severe hyperbilirubinemia due to hereditary hemolytic anemia, OMIM 266200) or structural defects not easily recognizable in the perinatal period (e.g., primary glaucoma, OMIM 231300).
Analysis of developmental disorders by phenotype and genotype
To understand better the genetic mechanisms for abnormal development, we first categorized the 162 entries by genotype information. The genes that cause structural defects were stratified by function. From 144 entries, in which the function of the disease gene has been well characterized, 49 entries are due to mutations in genes encoding transcription factors; 26 conditions are due to mutations in structural proteins; 27 conditions are due to mutations in enzymes; 13 conditions are due to mutations in receptors, and 7 are due to mutations in tumorsuppressor genes. While there is a preponderance of birth defects due to gene mutations encoding transcription factors (at least 34%, or 49 of the 144 conditions), one can conclude that congenital structural malformations are caused by mutations in a heterogeneous group of genes. These functional categories are rather arbitrary because some proteins have more than one function, depending on the developmental timing and process. No particular phenotype-genotype correlations emerge from mutations in genes of a given functional category. For example, enzyme deficiencies may cause diverse clinical features ranging from isolated hypospadias (OMIM 264600) to severe multiorgan malformations, as in the case of Lowe oculocerebrorenal syndrome (OMIM 309000). Transcription factors may be mutated in isolated structural defects such as hypodontia (OMIM 106600) or dysmorphic syndromes involving multiple-organ systems, such as Pallister-Hall syndrome (OMIM 146510). This latter condition is due to mutations in the zinc finger transcription factor GLI3 (OMIM 165240), which is of interest because it can also cause several other phenotypically overlapping malformations -including Greig cephalopolysyndactyly (OMIM 175700) and postaxial polydactyly type A1/B (OMIM 174200) and type IV (OMIM 174700). It is beyond the scope of this review even to list, let alone describe all the human phenotypes resulting from defects in the factors of transcriptional regulation. The interested reader is directed to an authoritative and detailed text, 'Transcription Factors and Human Disease' (4).
Second, we categorized the entries by major phenotypic features. If more than one phenotype, such as Crouzon syndrome (OMIM 123500; Tables 1 and 2 .
Third, we categorized the entries by disease gene. If a phenotype is caused by more than one disease gene, then the phenotype was noted in more than one 'item' in Tables 1 and 2 . An example of genetic heterogeneity is Pfeiffer syndrome, which can be due to mutations in FGFR1, FGFR2, and FGFR3 (Table  1 , items 2, 3, and 10). Analyses of several genes that yield the same phenotype may be examples of redundancy of gene function and gene-gene interaction. Usually, at the beginning of the text of each OMIM entry, the associated disease genes are mentioned in a few sentences that are set off as a separate paragraph. Among the 162 entries, there are 32 that show genetic heterogeneity.
A summary of the above analyses is presented in Tables 1 and 2 . These tables list a total of 247 items, representing a given phenotype and each of its associated allelic variants and disease genes as separate items. In Table 1 , these items have been categorized as representing either skeletal and connective tissue disorders (77 items) or deafness, pigmentary abnormalities, and Hirschsprung disease (16 items). Additional categories are axis/laterality disorders (8 items), ocular disorders (14 items), genital and endocrine disorders (13 items), DNA repair defects (19 items), neurologic disorders (30 items), skin disorders (45 items), and vascular disorders (4 items), all in Table 2 . These groupings are arbitrary, with additional items describing syndromes with major features in more than one category (miscellaneous, 21 items), and, therefore, they are not readily grouped.
In Table 1 , we present details of 93 of the items that are illustrative of the genetic basis of human malformations. The examples discussed above are listed with information on the phenotype, the function of the disease gene, and the corresponding mouse model. As evident from Table 1 , there are mouse models for at least 32 of these congenital syndromes, and the vast majority of the cases are due to null mutations, and the mouse and human phenotypes correlate. Eleven of the mouse models have arisen spontaneously. Phenotypes of mutant mice can be instrumental in suggesting a potential candidate gene for a human condition. For example, 'extra toes', a Gli3 spontaneous mutant mouse ( Table 1 , items 52 -55) and a Twist heterozygous null mutant mouse (Table 1 , item 17) were helpful in the identification of human mutant genes for several skeletal dysplasias. These mouse models will be useful in delineating modifying genes that cause phenotypic variability often noted in autosomal dominant conditions.
Analysis of similar phenotypes reveals different types of genes involved in common developmental pathways
By grouping these OMIM entries by phenotype, we can learn several important lessons about development. Identification of identical or similar clinical phenotypes caused by mutations in different genes may provide useful information on how individual genes participate and interact in a common developmental pathway. For example, there are several Waardenburg syndrome-like phenotypes, types 1, 2, 2A, 3, and 4, that result from mutations in at least five genes, PAX3, MITF, EDN3, ED-NRB3 and SOX10 (see under heading 'Deafness, pigmentary abnormalities, and Hirschsprung disease' in Table 1 ). These phenotypes have a combination of features caused by abnormalities of neural crest cells, including deafness, pigmentary abnormalities, and Hirschsprung disease. Deafness is a typical finding with PAX3 and MITF mutations. However, mutations in END3, EDNRB3, and SOX10 manifest with other symptoms typical for Waardenburg -Shah syndrome (OMIM 277580, Table 1 , items 84 -86), such as pigmentary changes and Hirschsprung disease, but not deafness. These phenotype -genotype correlations suggest that these genes participate in more than one developmental pathway involving the development of the auditory apparatus, pigmentation, and/or the innervation of the gastrointestinal tract.
Deciphering the exact interactions among these genes may be obvious as in the case of the endothelin-beta receptor EDNRB3 and its ligand EDN3, and, indeed, mutations of both of these genes result in the same phenotype of Waardenburg-Shah syndrome. However, it is less intuitive how these two genes interact with the transcriptional activator SOX10, which, when mutated, causes the identical phenotype. Starting with this information from OMIM, a developmental biologist may design a set of experiments to address whether and how these genes interact. In turn, genes or molecules that interact with SOX10 are prime candidates for mutations in Waardenburg syndrome patients who do not have mutations in the above mentioned genes, or in patients with inner-ear defects, pigmentation abnormalities, and/ or Hirschsprung disease (6) .
Mutations in PAX3 and MITF, encoding transcription factors, are noted in OMIM to cause Waardenburg syndrome types 1, 2, 2A, and 3. As suggested by these phenotype-genotype correlations, these two genes interact. In fact, PAX3 was found to transactivate the MITF promoter in type 1 (7, 8) . Furthermore, mutations in MITF are responsible for Waardenburg syndrome type 2A (OMIM 193510) . It is known that MITF transactivates the gene for tyrosinase (TYR, OMIM 203100), a key enzyme for melanogenesis. Mutations of TYR, together with MITF mutations, are the cause of a digenic condition, Waardenburg syndrome type 2 with ocular albinism and sensorineural deafness (OMIM 103470). The absence of melanocytes affects pigmentation in the skin, hair, and eyes, and hearing function in the cochlea. Therefore, hypopigmentation and hearing loss in Waardenburg syndrome type 2 are likely to be the result of an abnormality of melanocyte differentiation and/or melanin production caused by mutations in both genes.
With regard to the development of the innervation of the gastrointestinal tract, additional genes are involved; RET, GDNF, and NRTN are disease genes associated with Hirschsprung disease (OMIM 142623; Table 1 , items 87-91). Mutations of the RET gene occur in Hirschsprung disease, regardless of the length of the aganglionic segment. Mutations in ligands for RET, GDNF, and NRTN probably cannot cause Hirschsprung disease on their own, but may contribute to the phenotype in combination with mutant RET. This is another example of oligogenic effects on development.
Conclusion
OMIM provides excellent information resources for the biomedical professional. While providing a wealth of easily accessible and updated information to the user interested in a particular gene or phenotype, the huge amount of available information requires a considerable amount of time and effort in order to analyze and perform more sophisticated queries. To date, OMIM is the only genetic knowledgebase attempting to provide information on all known genes, loci, and phenotypes. No other publicly available database can assist in the identification and analysis of all or a portion of human disorders that result from mutations in a particular group of genes. As in the present review, OMIM could be queried as a dysmorphology database. While other existing genetic databases are of enormous benefit to the biomedical community, the majority, if not all of them, are focused on a particular aspect of genetic medicine -dysmorphology (9), DNA sequences, gene expression patterns, protein analysis, etc. OMIM serves as a common link that brings together all of the existing genetic databases and greatly enhances the stimulation of biologic interest and investigation, not only at the genomic level, but also at the clinical level in many biomedical disciplines.
